364 related articles for article (PubMed ID: 19665953)
1. Current and novel therapeutic options for irritable bowel syndrome management.
Camilleri M; Andresen V
Dig Liver Dis; 2009 Dec; 41(12):854-62. PubMed ID: 19665953
[TBL] [Abstract][Full Text] [Related]
2. Irritable bowel syndrome: recent and novel therapeutic approaches.
Andresen V; Camilleri M
Drugs; 2006; 66(8):1073-88. PubMed ID: 16789793
[TBL] [Abstract][Full Text] [Related]
3. [Novel therapeutic approaches in the treatment of irritable bowel syndrome].
Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
Orv Hetil; 2007 May; 148(20):923-8. PubMed ID: 17509972
[TBL] [Abstract][Full Text] [Related]
4. Current medical treatments of dyspepsia and irritable bowel syndrome.
Camilleri M; Tack JF
Gastroenterol Clin North Am; 2010 Sep; 39(3):481-93. PubMed ID: 20951913
[TBL] [Abstract][Full Text] [Related]
5. The brain-gut axis in irritable bowel syndrome--clinical aspects.
Mach T
Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
[TBL] [Abstract][Full Text] [Related]
6. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.
Camilleri M; Chang L
Gastroenterology; 2008 Dec; 135(6):1877-91. PubMed ID: 18848833
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in the therapy of irritable bowel syndrome.
Saad RJ; Chey WD
Expert Opin Investig Drugs; 2008 Feb; 17(2):117-30. PubMed ID: 18230048
[TBL] [Abstract][Full Text] [Related]
8. Treatment options in irritable bowel syndrome.
Farthing MJ
Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
Lee KN; Lee OY
World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutical approaches for treatment of irritable bowel syndrome].
Siegert F; Nieber K
Med Monatsschr Pharm; 2010 Aug; 33(8):285-92; quiz 293-4. PubMed ID: 21189648
[TBL] [Abstract][Full Text] [Related]
11. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
Mayer EA; Tillisch K; Bradesi S
Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Li X; Li B; Zhang J; Chen T; Wu H; Shi X; Ma J; Qin J; Tang X; Wang F
Medicine (Baltimore); 2021 Jan; 100(4):e24361. PubMed ID: 33530231
[TBL] [Abstract][Full Text] [Related]
13. Investigational agents for the irritable bowel syndrome.
Ghaith O; El-Halabi M; Hashash JG; Sharara AI
Expert Opin Investig Drugs; 2010 Oct; 19(10):1161-78. PubMed ID: 20836617
[TBL] [Abstract][Full Text] [Related]
14. Irritable bowel syndrome: focus on otilonium bromide.
Boeckxstaens G; Clavé P; Corazziari ES; Tack J
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
[TBL] [Abstract][Full Text] [Related]
15. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
16. Drugs for Irritable Bowel Syndrome.
Med Lett Drugs Ther; 2020 Mar; 62(1594):25-32. PubMed ID: 32324172
[No Abstract] [Full Text] [Related]
17. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder.
Lembo A; Weber HC; Farraye FA
Drugs; 2003; 63(18):1895-905. PubMed ID: 12930162
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.
Kane JS; Ford AC
Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693
[TBL] [Abstract][Full Text] [Related]
19. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery approaches to irritable bowel syndrome.
Hornby PJ
Expert Opin Drug Discov; 2015; 10(8):809-24. PubMed ID: 26193876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
